AccuStem Sciences, Inc.
ACUT
$1.85
-$0.12-6.09%
OTC PK
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -17.20% | 24.84% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -8.86% | 18.36% | |||
| Operating Income | 8.86% | -18.36% | |||
| Income Before Tax | 8.86% | -18.36% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 8.86% | -18.36% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 8.86% | -18.36% | |||
| EBIT | 8.86% | -18.36% | |||
| EBITDA | 8.82% | -18.56% | |||
| EPS Basic | 27.75% | -8.81% | |||
| Normalized Basic EPS | 27.78% | -8.54% | |||
| EPS Diluted | 27.75% | -8.81% | |||
| Normalized Diluted EPS | 27.78% | -8.54% | |||
| Average Basic Shares Outstanding | 26.32% | 8.73% | |||
| Average Diluted Shares Outstanding | 26.32% | 8.73% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||